GLP-1 RA use, technology, unique needs of individuals are recurring themes in the latest updates to the Standards of Care in Diabetes

ADA 2026 Scientific Sessions: New GLP-1 Drugs and Diabetes Research Highlights

In this JAMA Medical News podcast, Jennifer Abbasi interviews Dr. Rita Kalyani, the ADA's Chief Scientific and Medical Officer, about key hi

National Psoriasis Foundation Review Examines GLP-1 Receptor Agonists for Psoriasis with Metabolic Comorbidities

This review from the US National Psoriasis Foundation Medical Board provides an evidence-informed narrative synthesis on GLP-1 receptor agon

Conflicts of interest threaten integrity of GLP-1 therapy guidance amid rapid adoption

This article discusses the rapid uptake and commercial success of GLP-1 receptor agonists for obesity management, highlighting their clinica

<![CDATA[GLP-1 Access Depends on Smarter Benefit Design and Patient Support]]>

AHA Statement Emphasizes Physical Activity's Role in Obesity Care Alongside GLP-1 Medications

JAMA Medical News Director Jennifer Abbasi and Staff Writer Samantha Anderer discuss a new American Heart Association scientific statement o

Personal Reflection on Using Proprietary Medical Devices for Diabetes Management

The article discusses the author's personal experience with diabetes and their difficult choice to use a proprietary continuous glucose moni